Incannex Healthcare Authorizes $20 Million Share Repurchase Program
MELBOURNE, Australia and NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company developing i...
When is the repurchase program scheduled to commence and what is the anticipated execution timeline?
What is the expected impact of the buyback on the stock’s price and earnings per share (EPS) in the short term?
How will the $20 million share repurchase affect Incannex’s cash reserves and liquidity?
18 days ago